Long-lived rivals: actuaries say Biden and Trump are not too old for office

Link: https://www.ft.com/content/ad3a97fc-6394-471b-95b6-a46576808f4a?accessToken=zwAF-p9xpktIkdOtOpf8Y5RHG9OVtqRldoCPSg.MEUCIDgGL7wEhhf0DcMprg_1VYV0TDGsyWYpn56E-cBhCGWoAiEA_YjdblG4oKzNoagG66jcPOhEtvtht7Du5gnihbZVDfU&sharetype=gift&token=82960010-bfb1-44e4-a677-de6e47ba5545



Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.comT&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found here.

Any predictions are by their nature uncertain, yet a longevity modelling firm has forecasted that both candidates are likely to live well beyond the end of the next presidency in 2029. According to Club Vita, actuarial data suggests both men could have more than another decade ahead of them.

The company, which offers analytical services to insurers, said its US model suggested Biden has a life expectancy of another 11 years, taking him to 91. Trump has 14 more years to look forward to, per the model, meaning he would die at 90.

The model’s inputs include affluence, marital status, and employment. These key demographics for both Biden and Trump put them in the same favourable categories for the main factors, including addresses in the top category for life expectancy: the analysts used Trump’s Palm Beach address and Biden’s Delaware home.

Erik Pickett, a New Jersey-based actuary for Club Vita, said a wide range of factors could prove its model wrong, from whether the candidates “are in significantly different health to the average of someone with the same characteristics” to the fact that presidents have “access to higher quality medical treatments” than the typical American.

Author(s): Ian Smith in London and David Crow in New York

Publication Date: 30 April 2023

Publication Site: FT.com

Life expectancy across the UK




The ONS (‘Office of National Statistics) produces annual updates on period life expectancy in the UK – the so-called National Life Tables. The latest tables are based on the 2018 to 2020 period, and therefore are the first to pick up the impact of the COVID-19 pandemic. Given the significantly increased death rates seen in 2020, this fall in life expectancy is not unexpected. However, it is important to note that the headline figures hide a wide variety of underlying impacts at a more granular level.

Author(s): Conor O’Reilly

Publication Date: 27 Sept 2021

Publication Site: Club Vita

Mega trend 10: The democratization of longevity

Link: https://www.clubvita.us/news-and-insights/mega-trend-10-the-democratization-of-longevity



Illustrated below is the evolution of life expectancy at birth for seven Organization for Economic Co-operation and Development (OECD) countries: Canada, Hungary, Japan, Latvia, Poland, the United Kingdom, and the United States. Across the seven countries, male life expectancy at birth ranged from 64.8 years to 68.2 years in 1960, and 69.8 years to 81.1 years in 2017, demonstrating an increase in the inequality of life expectancy of almost eight years between these countries over the period. For females, the increase was approximately four years. The inequality in life expectancy is more apparent and unsettling if we consider, for example, developing countries in Africa, averaging a life expectancy of around 63 years in 2019.


Altogether, I believe greater democratization of longevity is achievable with the adoption of health technologies, while ensuring they are accessible and affordable. I am hopeful but I see several challenges ahead. Such a reality will be reliant on governments, health care professionals, and patients’ acceptance and reliance on what the future of health holds. It will also require global partnerships to build out ecosystems that will facilitate inclusive innovation.

Author(s): Shantel Aris

Publication Date: 22 Sept 2021

Publication Site: Club Vita

30 really is the new 20 (for some people – determining who they are will become crucial for pension plans and insurers)

Link: https://www.clubvita.us/news-and-insights/mega-trend-9-30-really-is-the-new-20-for-some-people-determining-who-they-are-will-become-crucial-for-pension-plans-and-insurers


Moshe Milevsky claims that someone could be up to 20 years younger biologically than their chronological age, and that biological age is a much be a better way of determining a person’s longevity. If this is true, is there a way that organizations that specialize in longevity and/or mortality and that use mathematical calculations in order to determine risk could use biological age instead of chronological age to predict future health and longevity?


There are two methods used to calculate biological age, coined by Milevsky as the “living” methodology or the “dying” methodology a.k.a. the mortality-adjusted approach.

Both methods begin with the collection of data. A researcher would first gather data from a large group of people at a wide range of ages, collecting biological samples and measurements in order to record various physiological and molecular variables (such as heart rate, blood pressure, mutations of DNA, or the presence of certain proteins in the blood). Researchers may also collect data on variables that they believe will be correlated with enhancement or deterioration of a person’s physiological condition, such as their wealth, occupation or even their appearance or number of Facebook friends!

Author(s): Nikiya Marilla

Publication Date: 16 Sept 2021

Publication Site: Club Vita

Grim COVID-19 Scenario Could Cut Pension Liabilities

Link: https://www.thinkadvisor.com/2021/03/09/grim-covid-19-scenario-could-slash-pension-liabilities/


The pandemic could also slash pension plan sponsors’ liabilities, by making ordinary health care an expensive luxury — and driving up the U.S. death rate for decades to come.

Analysts at Club Vita US LLC have presented those scenarios in a look at the possible effects of the COVID-19 pandemic on three types of U.S. pension plans: defined benefit plans sponsored by single employers; defined benefit plans sponsored by multiple private-sector employers; and defined benefit plans sponsored by government employers.

The analysts’ work reflects the same kinds of effects that might affect blocks of life insurance policies, blocks of annuities, and life settlement portfolios.

Author(s): Allison Bell

Publication Date: 9 March 2021

Publication Site: Think Advisor